Clinical Trials
2 trialsPrimary Myelofibrosis × N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide × Clear all
NCT03441113 2026-04-20
Extended Access of Momelotinib in Adults With Myelofibrosis
GlaxoSmithKline
Phase 2 Active not recruiting
NCT02124746 2023-06-18
Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia
Sierra Oncology LLC - a GSK company
Phase 2 Completed